Vectisol® is dedicated to organ, tissue and cell preservation. This molecular complex developed by BioCydex optimizes organ preservation by struggling against the Ischemia-Reperfusion injuries.
Vectisol® is an additive to the commercial “preservative solutions”.
Vectisol® opens the possibility of expanding the eligibility criteria of organ donors. Preclinical trials in kidney transplantation have demonstrated that Vectisol® achieves more rapid normal creatinine level and more rapid resumption of normal kidney functions. Vectisol® is also expected to extend the life expectancy of the graft and to increase the preservation time and therefore to contribute in optimizing the management of the organ distribution networks.
We have validated the non-toxicity, the efficiency, the benefit and the industrial process for the production of Vectisol®. The product is currently under regulatory evaluation.
Vectisol® technology was simultaneously patented in France and US and is undergoing international extensions.
Ready for use, Long-V is a 250 mL sterile and non-pyrogenic solution for the flushing and storage of organs, tissues and cells between 2 and 25°C. Long-V contains our innovative molecular complex, 56-SC, which is able to rule out the ischemic and reperfusion damages. The Long-V solution is labeled for research use only.
Solvamax® cyclodextrins are used for the capture and solubilization of active principles for the pharmaceutical and biology engineering fields. Solvamax® has revealed its outstanding capacity to enhance the solubility of active principles in pharmaceutical applications (oncology, ophthalmology,…) as well as in the molecular diagnostics field (microbiology, fluorometry,…)
Proteosol® cyclodextrins are dedicated to solve the problems associated with the solubilization, stabilization of peptides and proteins in the bioengineering and pharmaceutical fields.